Beijing Sinotau International Pharmaceutical Technology Co., Ltd. (09941)
Summary
Biotech firm Sinotau is now taking subscriptions at HK$52.00-68.00, closing 19 November and listing 24 November, with grey-market trading on 23 November; it focuses on radiopharmaceutical diagnostics and therapies.
Why this matters
Covers Subscription and Sponsor · Published within 6 hours
Source: FinKit IPO Snapshot · finkit.hk
Featured in Daily digest issue No. 1 (November 17, 2026)